Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes


Creative Commons License

Onat A., KOROGLU B., Can G. , KARAGÖZ A., Yuksel M., Aydin M.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.14, ss.26-33, 2014 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 14 Konu: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5152/akd.2013.5009
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Sayfa Sayısı: ss.26-33

Özet

Objective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metabolic syndrome (MetS), type-2 diabetes and coronary heart disease (CHD) in the general population.